The Adverse Analytical Finding (AAF)1 returned for the non-specified prohibited substance mesterolone metabolite 3α-hydroxy-1α-methyl-5α-androstan-17-one (classified as S1. Anabolic Androgenic Steroid) and the specified prohibited substances 5-methylhexan-2-amine and heptaminol (classified as S6. Stimulants according to the Prohibited List of the World Anti-Doping Agency (WADA)).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 10 February 2022 in Zhangjiakou, China. The result was reported by the WADA-accredited laboratory of Beijing on 15 February 20222.
The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the IOC Anti-Doping Rules applicable to the Olympic Winter Games Beijing 2022. This means that the athlete is prevented from competing, training, coaching, or participating in any activity, during the Olympic Winter Games Beijing 2022.
The athlete has the right to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division (CAS ADD).
The athlete also has the right to request the analysis of the B-sample.
Given that the case is underway, there will be no further comments during the ongoing proceeding.